| Wellcome Trust Case Control Consortium 2 |
cohort |
3 |
2 |
WTCCC2 |
| Wernicke-Korsakoff syndrome |
phenotype |
4 |
2 |
WKS |
| Wernicke's encephalopathy |
phenotype |
2 |
2 |
WE, WKS, Wernicke Encephalopathy |
| Western Europe |
cohort |
6 |
3 |
|
| WHI |
cohort |
2 |
1 |
|
| White |
phenotype |
26 |
8 |
Caucasian, European ancestry, White, White adolescents, White participants, White respondents, Whites, self-identified as White, self-identified white, white, whites |
| White adolescents |
cohort |
5 |
3 |
White, white adolescents |
| White children |
cohort |
3 |
1 |
white children |
| White females |
cohort |
2 |
1 |
|
| White men |
cohort |
6 |
4 |
18-to-25-year-old White males |
| white participants |
cohort |
11 |
5 |
Caucasian, White, White adults, White individuals, White participants, White respondents, Whites, self-identified White participants, white, white individuals |
| White race |
phenotype |
3 |
1 |
white race |
| whites |
cohort |
19 |
9 |
Caucasian, Caucasians, European Americans, White, White Americans, White adults, White individuals, White individuals in young adulthood, White participants, White population, White respondents, White students, Whites, non-Hispanic Whites, white, white individuals, white males, white participants |
| whole exome sequencing |
drug |
4 |
2 |
WES, whole exome, whole exome sequencing |
| widowed |
phenotype |
5 |
— |
|
| wild-type |
cohort |
5 |
2 |
WT, wild-type P0 animals |
| wild-type mice |
cohort |
35 |
15 |
WT, WT littermates, WT mice, WT sham mice, control, control animals, control cohort, control mice, controls, naïve WT, wild type animals, wild type mice, wild-type, wild-type mice, wildtype control mice, wildtype mice, wild‑type mice |
| WIN 55,212-2 |
drug |
3 |
2 |
WIN, WIN55,212-2, WIN55212-2 |
| Win 55212-2 |
drug |
2 |
1 |
CB1 agonist Win 55212-2 |
| WIN55,212-2 |
drug |
2 |
2 |
WIN, WIN 55,212-2, WIN55212-2 |
